Replies to post #363900 on ORIONS Money Stocks

[matt24d]

I do not have the link but looks like Barrons put an article on CPXX.

The percentage of patients alive 12 months after randomization was 41.5% on the Vyxeos arm, compared to 27.6% on the 7+3 arm. The percentage of patients alive 24 months after randomization was 31.1% on the Vyxeos arm, compared to 12.3% on the 7+3 arm.



Now we have the small offering out the way this one can finally find its legs.